Randomised phase II study of panitumumab plus irinotecan versus cetuximab plus irinotecan in patients with KRAS wild-type metastatic colorectal cancer refractory to fluoropyrimidine, irinotecan and oxaliplatin (WJOG 6510G)
| Image |  |
|---|---|
| Description | scientific article published on 08 June 2020 |
| Author/s |
author: Ichinosuke Hyodo Narikazu Boku |
| Publication date | June 8, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |